Clinical Trial Update: Phase II Study to Evaluate Fenofibrate Therapy in Patients With Smoldering or Symptomatic Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase II study evaluating fenofibrate therapy in patients with smoldering or symptomatic multiple myeloma has been terminated; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• FENOFIBRATE (Fenofibrate)

Snippet

Sponsor: University of Miami | Conditions: Multiple Myeloma | Phase 2 | Status: TERMINATED | Results posted: 2017-06-14